Covered recipient · General Payments record
KEVIN GANESH
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2022–2025
$2,535.98
- Reported across 121 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $310.12 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Melinta Therapeutics, Inc. | $62.59 | 3 |
| Smith+Nephew, Inc. | $54.35 | 3 |
| ABBVIE INC. | $50.14 | 3 |
| ViiV Healthcare Company | $44.74 | 3 |
| Shionogi Inc | $34.11 | 2 |
| Amgen Inc. | $26.67 | 1 |
| PFIZER INC. | $22.72 | 1 |
| Merck Sharp & Dohme Corporation | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.24 | 01/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201897657 | CMS |
| ABBVIE INC. | $18.63 | 04/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201897659 | CMS |
| ABBVIE INC. | $17.27 | 10/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201897661 | CMS |
| Amgen Inc. | $26.67 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228297902 | CMS |
| Melinta Therapeutics, LLC | $29.59 | 02/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1221035763 | CMS |
| Melinta Therapeutics, LLC | $16.60 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1221030878 | CMS |
| Melinta Therapeutics, LLC | $16.40 | 05/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1221030822 | CMS |
| Merck Sharp & Dohme LLC | $14.80 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238240355 | CMS |
| PFIZER INC. | $22.72 | 12/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231167418 | CMS |
| Shionogi Inc | $13.93 | 04/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250722049 | CMS |
| Shionogi Inc | $20.18 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250722081 | CMS |
| Smith+Nephew, Inc. | $16.00 | 01/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242270769 | CMS |
| Smith+Nephew, Inc. | $20.12 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242270771 | CMS |
| Smith+Nephew, Inc. | $18.23 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1242270773 | CMS |
| ViiV Healthcare Company | $17.21 | 01/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189558974 | CMS |
| ViiV Healthcare Company | $13.78 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189561254 | CMS |
| ViiV Healthcare Company | $13.75 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189518290 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.